Loading company…
Riskpilot
← Back to search
Sign in
Get full access
LUNDBECK COGNITIVE THERAPEUTICS A/S
A/S
Dissolved
CVR 28674848
Ottiliavej 9
Manufacture of pharmaceutical preparations · NACE 2120
Est. 2006
— employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2012
DKK -31,8M
EBITDA margin
100.0%
Equity ratio
-62.9%
Financial strength
Net profit 2012
DKK -28,6M
EBITDA — year on year
DKK millions
0M
-10M
-20M
-30M
-40M
-32M
2012
Key figures
Annual report 2012
Revenue
DKK -31,8M
—
EBITDA
DKK -31,8M
—
Net profit
DKK -28,6M
—
Total assets
DKK 54,5M
—
Equity
DKK -34,2M
—
Employees
—
—
Company information
Legal name
LUNDBECK COGNITIVE THERAPEUTICS A/S
CVR number
28674848
Legal form
Aktieselskab
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
14. december 2006
Share capital
DKK 500.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2012-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af et medlem af bestyrelsen, af en direktør eller af den samlede bestyrelse.
Contact
Address
Ottiliavej 9
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of pharmaceutical preparations
Companies in København
All Denmark companies
Revenue
DKK millions
0M
-9M
-18M
-28M
-37M
-32M
2012
EBITDA
DKK millions
0M
-9M
-18M
-28M
-37M
-32M
2012
Income statement
DKK thousands
Item
2012
Revenue
-31.847
Staff expenses
-0
EBITDA
-31.847
Depreciation & amort.
-4.704
EBIT
-36.551
Net financials
1.760
Profit before tax
-34.791
Tax
-6.151
Net profit
-28.640
Balance sheet
DKK thousands
Item
2012
Total assets
54.471
Equity
-34.239
Long-term debt
36.149
Short-term debt
39.123
Total debt
75.272
Financial ratios
5-year trend
EBITDA margin
-3184700000.0%
This company
15.8%
Market median
-20156329214% vs market
2012
2012
Equity ratio
-62.9%
This company
38.2%
Market median
-265% vs market
2012
2012
Return on equity
-2864000000.0%
This company
18.4%
Market median
-15565217491% vs market
2012
2012
Net profit margin
-2864000000.0%
This company
8.1%
Market median
-35358024791% vs market
2012
2012
Asset turnover
-0.58×
This company
1.12×
Market median
-152% vs market
2012
2012
Debt / equity
2.59×
This company
0.62×
Market median
-318% vs market
2012
2012
Annual reports & filings
Annual report 2012
Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (1)
AG
Anders Gersel Pedersen
Management
Management
2006 – 2013
Board of directors
Non-executive oversight
Name
Role
Member since
Former (4)
CT
Claus Tycho Bræstrup
Chairman
2006 – 2008
UA
Ulf Arne Wiinberg
Chairman
2008 – 2013
AC
Anne-Mette Carlstedt
Board of Directors
2007 – 2013
HH
Hans Henrik Munch-Jensen
Board of Directors
2006 – 2007
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of LUNDBECK COGNITIVE THERAPEUTICS A/S also hold positions in
0
other companies.
Person
Role here
Other companies
Anders Gersel Pedersen
Management
0 companies
Claus Tycho Bræstrup
Chairman
0 companies
Ulf Arne Wiinberg
Chairman
0 companies
Anne-Mette Carlstedt
Board of Directors
0 companies
Hans Henrik Munch-Jensen
Board of Directors
0 companies